Clinical Trials Directory

Trials / Completed

CompletedNCT00517725

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure: Effects on Exercise Capacity and Hypoxia, Chemoreceptor Response, Pulmonary Function

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Centro Cardiologico Monzino · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators test the hypothesis that different beta-blockers had a different influence on chemoreceptor response and lung diffusion capacity. Both could influence exercise capacity in normoxic as well as hypoxic conditions.

Conditions

Interventions

TypeNameDescription
DRUGcarvedilol
DRUGbisoprolol
DRUGNebivolol

Timeline

Start date
2007-07-01
Completion
2010-05-01
First posted
2007-08-17
Last updated
2010-09-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00517725. Inclusion in this directory is not an endorsement.

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure (NCT00517725) · Clinical Trials Directory